Barclays Portfolio holdings
Barclays is a British universal bank whose roots go back to 1690, when the Quakers John Freame and Thomas Gould started a goldsmith banking business in London. The Barclays name came into the business in 1736, when James Barclay, son-in-law of founder John Freame, became a partner. Barclays launched the UK's first credit card, Barclaycard, in 1966, and in 1967 put the world's first cash machine in a branch in Enfield. In 2008 Barclays bought the North American operations of Lehman Brothers, and in 2009 it sold its Barclays Global Investors unit, home of the iShares ETFs, to BlackRock. It runs five divisions: UK consumer banking, UK corporate banking, private banking and wealth management, an investment bank and a US consumer bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KLA
KLAC
|
+$355M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$304M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$267M |
| 4 |
Gilead Sciences
GILD
|
+$239M |
| 5 |
Visa
V
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$388M |
| 2 |
Wells Fargo
WFC
|
+$370M |
| 3 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$295M |
| 4 |
Alibaba
BABA
|
+$234M |
| 5 |
IBM
IBM
|
+$210M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 65.28% |
| 2 | Technology | 5.65% |
| 3 | Healthcare | 5.43% |
| 4 | Financials | 4.25% |
| 5 | Communication Services | 3.56% |
Similar funds
Barclays's Q1 2016 Portfolio in Review
As of Q1 2016, Barclays held 6,944 positions worth $65.6B, down 20% from $82.3B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Barclays withdrew a net $3.53B in Q1 2016, closing 589 positions and reducing 2,923 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $295M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 65% of assets, down from 68% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Barclays opened a new position in State Street SPDR S&P Pharmaceuticals ETF worth $26M.
- Barclays's largest Q1 2016 buy was State Street SPDR S&P Pharmaceuticals ETF: 650,000 shares worth $26M.
- Barclays added most to KLA in Q1 2016, an estimated $355M increase.
- Barclays's biggest Q1 2016 reduction was Apple, cutting an estimated $388M.
- Barclays fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $295M.
- Barclays's ten largest holdings make up 29% of its $65.6B portfolio in Q1 2016.
- Barclays opened 766 new positions and closed 589 in Q1 2016.
- Barclays's portfolio value fell 20% quarter-over-quarter to $65.6B.
Based on Barclays's 13F filing for Q1 2016, filed 16 May 2016.